» Articles » PMID: 15723096

ClC-3 Chloride Channel is Upregulated by Hypertrophy and Inflammation in Rat and Canine Pulmonary Artery

Overview
Journal Br J Pharmacol
Publisher Wiley
Specialty Pharmacology
Date 2005 Feb 22
PMID 15723096
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

Cl- channels have been implicated in essential cellular functions including volume regulation, progression of cell cycle, cell proliferation and contraction, but the physiological functions of the ClC-3 channel are controversial. We tested the hypothesis that the ClC-3 gene (ClCn-3) is upregulated in hypertensive pulmonary arteries of monocrotaline-treated rats, and upregulated ClC-3 channel aids viability of pulmonary artery smooth muscle cells (PASMCs). Experimental pulmonary hypertension was induced in rats by a single subcutaneous administration of monocrotaline (60 mg kg(-1)). Injected animals developed characteristic features of pulmonary hypertension including medial hypertrophy of pulmonary arteries and right ventricular hypertrophy. Reverse transcriptase-polymerase chain reaction (RT-PCR), immunohistochemistry and Western immunoblot analysis indicated that histopathological alterations were associated with upregulation of the ClC-3 mRNA and protein expression in both smooth muscle cells of hypertensive pulmonary arteries and in cardiac myocytes. RT-PCR analysis of mRNA, extracted from canine cultured PASMCs, indicated that incubation with the inflammatory mediators endothelin-1 (ET-1), platelet-derived growth factor (PDGF), interleukin-1beta (IL-1beta) and tumor necrosis factor alpha (TNF alpha), but not transforming growth factor beta (TGFbeta), upregulated ClC-3 mRNA. Adenovirus-mediated delivery and overexpression of ClC-3 in canine PASMCs improved cell viability against increasing concentrations of hydrogen peroxide (H2O2, range 50-250 microM). In conclusion, upregulation of ClC-3 in rat hypertensive lung and heart is a novel observation. Our functional data suggest that upregulation of ClC-3 is an adaptive response of inflamed pulmonary artery, which enhances the viability of PASMCs against reactive oxygen species.

Citing Articles

Structural basis of adenine nucleotides regulation and neurodegenerative pathology in ClC-3 exchanger.

Wan Y, Guo S, Zhen W, Xu L, Chen X, Liu F Nat Commun. 2024; 15(1):6654.

PMID: 39107281 PMC: 11303396. DOI: 10.1038/s41467-024-50975-w.


ANO1, CaV1.2, and IP3R form a localized unit of EC-coupling in mouse pulmonary arterial smooth muscle.

Akin E, Aoun J, Jimenez C, Mayne K, Baeck J, Young M J Gen Physiol. 2023; 155(11).

PMID: 37702787 PMC: 10499037. DOI: 10.1085/jgp.202213217.


Chloride Channel-3 (ClC-3) Modifies the Trafficking of Leucine-Rich Repeat-Containing 8A (LRRC8A) Anion Channels.

Stark R, Nguyen H, Bacon M, Rohrbough J, Choi H, Lamb F J Membr Biol. 2022; 256(2):125-135.

PMID: 36322172 PMC: 10085862. DOI: 10.1007/s00232-022-00271-9.


MiR-1-3p that correlates with left ventricular function of HCM can serve as a potential target and differentiate HCM from DCM.

Li M, Chen X, Chen L, Chen K, Zhou J, Song J J Transl Med. 2018; 16(1):161.

PMID: 29885652 PMC: 5994246. DOI: 10.1186/s12967-018-1534-3.


Betaine Attenuates Monocrotaline-Induced Pulmonary Arterial Hypertension in Rats via Inhibiting Inflammatory Response.

Yang J, Zhou R, Zhang M, Tan H, Yu J Molecules. 2018; 23(6).

PMID: 29861433 PMC: 6100216. DOI: 10.3390/molecules23061274.


References
1.
Nakazawa H, Hori M, Ozaki H, Karaki H . Mechanisms underlying the impairment of endothelium-dependent relaxation in the pulmonary artery of monocrotaline-induced pulmonary hypertensive rats. Br J Pharmacol. 1999; 128(5):1098-104. PMC: 1571722. DOI: 10.1038/sj.bjp.0702878. View

2.
Cao Z, Hardej D, Trombetta L, Trush M, Li Y . Induction of cellular glutathione and glutathione S-transferase by 3H-1,2-dithiole-3-thione in rat aortic smooth muscle A10 cells: protection against acrolein-induced toxicity. Atherosclerosis. 2003; 166(2):291-301. DOI: 10.1016/s0021-9150(02)00331-3. View

3.
Rabinovitch M . Pulmonary hypertension: pathophysiology as a basis for clinical decision making. J Heart Lung Transplant. 1999; 18(11):1041-53. DOI: 10.1016/s1053-2498(99)00015-7. View

4.
Davies K . The broad spectrum of responses to oxidants in proliferating cells: a new paradigm for oxidative stress. IUBMB Life. 2000; 48(1):41-7. DOI: 10.1080/713803463. View

5.
Nicod L . Pulmonary hypertension. Swiss Med Wkly. 2003; 133(7-8):103-10. DOI: 10.4414/smw.2003.10026. View